SCHEMBL691296

SCHEMBL691296

CCCn1nc(C)cc1Nc1cc(Nc2ccccc2C(=O)O)c(Cl)cn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 2/20 0.56
FTO Q9C0B1 6/20 0.46
GFER P55789 1/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
USP2 O75604 1/20 0.42
MT-CO2 P00403 1/20 0.42
LMNA P02545 1/20 0.42
TTR P02766 1/20 0.42
PLA2G1B P04054 1/20 0.42
CYP1A2 P05177 1/20 0.42
PGR P06401 1/20 0.42
CYP3A4 P08684 1/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
AR P10275 1/20 0.42
CYP2C9 P11712 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL691652 0.92 PTK2 (0.57) PTK2FTOGFERMAPTMEN1
SCHEMBL691659 0.91 PTK2 (0.59) PTK2MAPK3MAPK1MAPK8JAK2
SCHEMBL690218 0.90 PTK2 (0.58) PTK2MT-CO2HPGDPTGS2MAPK3
SCHEMBL691084 0.90 PTK2 (0.47) PTK2MAPTLMNACYP1A2CYP2C9
SCHEMBL689985 0.90 PTK2 (0.45) PTK2MEN1KMT2AUSP2LMNA
SCHEMBL692967 0.88 PTK2 (0.73) PTK2MEN1KMT2APTGS2MAPK3
SCHEMBL691573 0.88 MAPK1 (0.50) PTK2FTOMEN1KMT2ALMNA
SCHEMBL691390 0.88 PTK2 (0.46) PTK2FTOLMNAMAPK3MAPK1
SCHEMBL697233 0.87 PTK2 (0.60) PTK2FTOGFERMAPTMEN1
SCHEMBL691211 0.87 PTK2 (0.44) PTK2FTOMEN1KMT2APTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421537-A1 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK GlaxoSmithKline LLC (US) 2012-02-29 EP disclosed
WO-2010062578-A1 PYRAZOLYLAMINOPYRIDINES AS INHIBITORS OF FAK GLAXOSMITHKLINE LLC (US) 2010-06-03 WO disclosed